Compare iShares Semiconductor ETF (SOXX) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Semiconductor ETF vs Twist Bioscience Corp — how do they compare? iShares Semiconductor ETF trades at $559.71 (market cap $48.19B), while Twist Bioscience Corp trades at $161.23 (market cap $10.08B). The key difference: iShares Semiconductor ETF is far larger — about 4.8× Twist Bioscience Corp's market cap, and iShares Semiconductor ETF is more actively traded (10,257,578 versus 4,229,037). Which is the better fit depends on your goals — on Pluang, investors hold iShares Semiconductor ETF for 46 Days and Twist Bioscience Corp for 27 Days on average.
| SOXX | TWST | |
|---|---|---|
Market Cap | $48.19B | $10.08B |
Volume | 10,257,578 | 4,229,037 |
Sector | Sector/Thematic | Health |
52-Week High | $655.01 | $205.00 |
52-Week Low | $268.10 | $25.45 |
Typical Hold Time | 46 Days | 27 Days |
Enterprise Value | — | $10.01B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SOXX trades at $559.40, down 4.04% over the past 24 hours, with technical indicators showing a bullish moving average signal but neutral oscillators. The semiconductor ETF faces mixed sentiment with strong AI-driven earnings growth projections but concerns about valuation premiums. Recent corporate actions include a 1:3 stock split scheduled for November 2026 and a $0.33 dividend payment in September 2026.
The outlook remains cautiously optimistic with AI infrastructure demand driving earnings growth, though high valuations and bearish bets from notable investors like Michael Burry present significant risks. Wall Street analysts maintain positive ratings based on semiconductor market expansion projections, with Bank of America forecasting near-doubling of the global chip market by 2030.
TWST trades at $155.65, down 6.78% over 24 hours, with a bearish technical signal and negative cash flows. Revenue growth is strong, reaching $377M in 2025, but the company remains unprofitable with a net income margin of -31.66%. Recent news highlights its role in Eli Lilly's AI-driven drug discovery platform, boosting sentiment despite earnings misses.
The outlook is mixed: analyst consensus is bullish with a $145.20 price target, but high valuation multiples and persistent losses pose risks. Investment opportunity hinges on AI partnerships driving future profitability, while execution risks and cash burn require careful monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares Semiconductor ETF
SOXX provides investors with exposure to U.S. companies that design, manufacture, and distribute semiconductors. It tracks the ICE Semiconductor Index, offering a targeted investment in the technology sector's foundational components, including firms that produce chips, related equipment, and services. SOXX is a key vehicle for investors seeking to capitalize on trends in artificial intelligence, 5G, and other technologies that rely heavily on advanced semiconductor technology.
Read more on SOXX →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
